Finance

Beta
Lists
CMP:ASX
Compumedics Ltd
A$0.26
0.00%
(0.00) 1D
Jun 3, 12:57:02 PM GMT+10  ·   AUD
All symbols
SymbolPriceChange% Change
Generating top insights for CMP...
Mkt. cap
51.96M
Avg. vol.
36.20K
Volume
0.00
P/E ratio
500.00
52-wk high
A$0.45
52-wk low
A$0.24
EPS
A$0.00
Shares outstanding
199.76M
No. of employees
175
Mkt. cap
51.96M
Avg. vol.
36.20K
Volume
0.00
P/E ratio
500.00
52-wk high
A$0.45
52-wk low
A$0.24
EPS
A$0.00
Shares outstanding
199.76M
No. of employees
175
News stories
From sources across the web
About Compumedics Ltd
CEO-
Employees175
Founded1987
Headquarters-
SectorMedical device
Websitecompumedics.com.au
Previous reportsAll values in AUD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in AUD
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Revenue
13.76M
13.76M
15.49M
15.49M
Cost of goods sold
6.11M
6.11M
7.51M
7.51M
Cost of revenue
6.11M
6.11M
7.51M
7.51M
Research and development expenses
173.00K
173.00K
1.03M
1.03M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
6.77M
6.77M
6.34M
6.34M
Operating expense
7.08M
7.08M
7.01M
7.01M
Total operating expenses
13.19M
13.19M
14.53M
14.53M
Operating income
569.00K
569.00K
962.00K
962.00K
Other non operating income
-
-
-
-
EBT including unusual items
245.50K
245.50K
599.00K
599.00K
EBT excluding unusual items
245.50K
245.50K
599.00K
599.00K
Income tax expense
322.50K
322.50K
465.50K
465.50K
Effective tax rate
131.36%
131.36%
77.71%
77.71%
Other operating expenses
134.50K
134.50K
-361.50K
-361.50K
Net income
-77.00K
-77.00K
133.50K
133.50K
Net profit margin
-0.56%
-0.56%
0.86%
0.86%
Earnings per share
-
-
-
-
Interest and investment income
-
-
-
-
Interest expense
-363.00K
-363.00K
-368.50K
-368.50K
Net interest expenses
-363.00K
-363.00K
-368.50K
-368.50K
Depreciation and amortization charges
-
-
-
-
EBITDA
696.00K
696.00K
1.06M
1.06M
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer